Precision lines shaping tomorrow’s battery landscape

Ilika Plc

Amid the steady hum of factory floors and the quiet churn of regulatory corridors, an event this September is gathering the industry’s most exacting minds to refine the art of battery creation. In Berlin, manufacturers, technology partners and policymakers will converge not in response to sensational breakthroughs, but to optimise the intricate choreography that turns raw materials into the cells empowering electric mobility and renewable grids.

As the push towards electrification accelerates, the spotlight is shifting from cell chemistry headlines to the meticulous orchestration of production lines. Investors gauging opportunities must look beyond the megawatt hours and kilowatt peaks, and consider the nuanced efficiencies that will dictate margins in the decade ahead. The 2nd Excellence in Battery Manufacturing conference, scheduled for 25–26 September 2025 in Berlin, offers a window into that precision frontier.

The gathering is emblematic of a maturing market, where the allure of novel materials yields to the pragmatic demands of scale. European manufacturers face the dual imperative of cost-competitiveness and conformity with evolving environmental mandates. Sessions on detectability and quality concepts in cell production underscore how imperceptible defects can cascade into costly recalls or safety incidents. For investors, the ability of a plant to integrate advanced inspection systems and data analytics will increasingly differentiate winners from laggards.

Cost discipline emerges as a leitmotif. With Chinese suppliers retaining an edge in volume output, European players must leverage lean design and localised supply chains. Presentations on achieving European cost-competitiveness will detail process automation and modular factory layouts, revealing the trade-offs between capital expenditure and operational agility. Such insights are vital for those assessing long-term capital projects, where even fractional improvements in yield can transform return profiles.

Collaboration between technology providers, material scientists and cell assemblers is another recurring theme. The conference’s agenda reflects the realisation that isolated advances, be it a novel electrolyte or a more conductive anode, cannot realise full potential without co-development frameworks. Investors should note how alliances and joint ventures are fast becoming the default route to de-risk scale-up, with implications for equity stakes and licensing revenues.

Among the more forward-looking topics is the transition towards solid-state architectures at gigascale. Ilika’s chief executive will share considerations for implementing these next-generation cells in mass-manufacturing contexts. While chemistry breakthroughs capture headlines, the true test lies in adapting roll-to-roll coating, stack assembly and thermal management systems to entirely new materials. The success of that endeavour will shape supply pipelines and valuations for years to come.

The agenda also addresses the emerging reliance on digital tools to uphold circular economy objectives. Data-driven tracking of material flows and AI-enabled predictive maintenance promise to slash downtime and resource waste. Those capabilities intersect with growing investor scrutiny of environmental, social and governance metrics. Firms that can credibly demonstrate closed-loop operations stand to earn both regulatory favours and differentiated valuations as sustainability criteria co-alesce into financial covenants.

Finally, with rising geopolitical tensions, the conference does not overlook cybersecurity and the challenges of integrating equipment sourced from diverse regions. Risk management in an era of smart factories extends far beyond physical safety protocols. A successful breach could halt production and erode trust among offtakers. Accordingly, investors must factor in the resilience of digital infrastructure when sizing plant investments or evaluating supply-chain exposures.

The 2nd Excellence in Battery Manufacturing conference unites experts to sharpen the processes, partnerships and platforms that underpin the next wave of battery capacity. From defect detection and cost optimisation to digital circularity and secure operations, the event reflects the intricate levers that will determine commercial success in energy storage.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika builds the manufacturing path for Goliath solid-state batteries

Ilika is building the manufacturing and licensing pathway needed to move its Goliath solid-state battery technology towards larger-scale commercial production.

Ilika: Stereax revenue growth and Goliath opportunities ahead

Morphose Capital Partners’ Dr Tom McColm discusses Ilika’s FY26 results, the outlook for Stereax commercial revenues, progress with Goliath and potential opportunities in automotive, defence and e-bikes.

Ilika CEO highlights Stereax revenue growth and Goliath defence interest

Ilika CEO Graeme Purdy discusses Stereax product revenue, planned M300 battery deliveries, Goliath 10Ah development, EV market trends and rising demand from the defence sector.

Ilika plc reaches a commercial turning point as new markets emerge for Stereax and Goliath (video)

Dr Tom McColm of Morphose Capital Partners explains why the company may be approaching an important commercial inflection point.

Ilika plc: Stereax Revenue Arrives as Goliath Draws Defence Interest (video)

Ilika plc CEO Graeme Purdy outlines how Stereax has started generating product-related revenue, why M300 battery deliveries remain on track and how Goliath’s 10Ah prototype is opening new opportunities in defence and sovereign battery supply.

Ilika builds commercial momentum across Stereax and Goliath batteries

Ilika Plc reports annual results for the year ended 30 April 2026, highlighting progress on its Stereax medical battery line and Goliath large-format batteries for EV, defence and consumer applications. The company began Stereax production and deliveries, shipped larger Goliath prototypes, secured further grant funding and raised £5 million post-period to accelerate commercialisation.

Search